Best online stocks for day and forex trader

Top alert for 2014: MYGN (50%), LIVE (45%), CTIC (115%), KOOL (88%), PZG (32%), GOLD (6%), IOC (6%), RSOL(18%), PLUG (70%), IMMU (26%)

Tuesday, June 30, 2015

Premarket Trading Ideas for July 1st: UWTI, GOGO, TLOG, JUNO, UVXY, XIV, ERX, VNDA, VTAE, AVAV, AAPL, DDD, LL,

IPO of the day:
TDOC great below 30.

Day Trading stocks:
UWTI, GOGO, TLOG, JUNO, BIOC, FREE, AAVL
Economic Calendar:
SessionTimeCurrencyEventImpactActualForecastPrev.
3:50EURFrench Manufacturing PMIlow50.550.5
3:55EURGerman Manufacturing PMImed51.951.9
4:00EURManufacturing PMImed52.552.5
8:15USDADP Employment Surveymed218201
9:45USDManufacturing PMIlow53.453.4
10:00USDConstruction Spendinglow0.42.2
10:00USDISM Manufacturinghigh53.152.8

Premarket Earning Report:
General Mills, Inc. ( GIS) is reporting for the quarter ending May 31, 2015. The food company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.71. This value represents a 5.97% increase compared to the same quarter last year. 

Constellation Brands Inc ( STZ) is reporting for the quarter ending May 31, 2015. The alcohol company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.22. This value represents a 14.02% increase compared to the same quarter last year. STZ missed the consensus earnings per share in the 3rd calendar quarter of 2014 by -3.48%. 
Paychex, Inc. ( PAYX) is reporting for the quarter ending May 31, 2015. The outsourcing company's consensus earnings per share forecast from the 20 analysts that follow the stock is $0.44. This value represents a 10.00% increase compared to the same quarter last year. In the past year PAYX has met analyst expectations twice and beat the expectations the other two quarters.

McCormick & Company, Incorporated ( MKC ) is reporting for the quarter ending May 31, 2015. The food company's consensus earnings per share forecast from the 5 analysts that follow the stock is $0.68. This value represents a 6.25% increase compared to the same quarter last year. In the past year MKC has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 9.38%. The "days to cover" for this stock exceeds 19 days. 

Acuity Brands Inc ( AYI) is reporting for the quarter ending May 31, 2015. The building company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.33. This value represents a 33.00% increase compared to the same quarter last year. AYI missed the consensus earnings per share in the 2nd calendar quarter of 2014 by -11.5%. The days to cover, as reported in the 6/15/2015 short interest update, increased 144.76% from previous report on 5/29/2015.

Unifirst Corporation ( UNF ) is reporting for the quarter ending May 31, 2015. The uniform company's consensus earnings per share forecast from the 6 analysts that follow the stock is $1.39. This value represents a 9.15% decrease compared to the same quarter last year. In the past year UNF has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 5.38%. 

AZZ Incorporated ( JAZZ) is reporting for the quarter ending May 31, 2015. The machinery company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.69. This value represents a 32.69% increase compared to the same quarter last year. 

Greenbrier Companies, Inc. ( GBX) is reporting for the quarter ending May 31, 2015. The transportation company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.60. This value represents a 55.34% increase compared to the same quarter last year. In the past year GBX has beat the expectations every quarter. The highest one was in the 1st calendar quarter where they beat the consensus by 27.64%. The "days to cover" for this stock exceeds 18 days. 
After Hour Report:
TetraLogic Pharmaceuticals Corporation (NASDAQ: TLOG41% HIGHER; announced preliminary data from the ongoing Phase 2A study of birinapant in combination with azacitidine in first line higher risk myelodysplastic syndromes (MDS). The study is being conducted as a precursor to the ongoing randomized Phase 2B study. In this study, birinapant was administered, at 13 mg/m2 twice a week, three weeks out of four, during a four week cycle in combination with the approved dose of azacitidine. The primary assessment of efficacy was the response rate using the modified International Working Group criteria (Cheson 2006) at the end of cycle four. Of the nine patients who entered the study, six completed four cycles of therapy and underwent a repeat bone marrow assessment. Three patients experienced a complete response, one patient experienced a bone marrow complete response, one patient experienced a partial response and underwent a stem cell transplant and one patient had stable disease. Three patients discontinued the study prior to receiving four cycles of treatment. The regimen was generally well tolerated, the most common side effects being fatigue, neutropenia and thrombocytopenia.
AeroVironment (NASDAQ: AVAV4.7% HIGHER; reported Q4 EPS of $0.32, $0.14 better than the analyst estimate of $0.18. Revenue for the quarter came in at $86.5 million versus the consensus estimate of $85.71 million. As of April 30, 2015, funded backlog (unfilled firm orders for which funding is currently appropriated to us under a customer contract) was $64.7 million compared to $65.9 million as of April 30, 2014. AeroVironment sees FY2016 revenue of $260-280 million, versus the consensus of $277.3 million.
Ballard Power (NASDAQ: BLDP4.3% LOWER; announced its intention to offer its common shares in an underwritten public offering. Ballard expects to grant the underwriters of the Offering a 30-day option to purchase up to an additional 15% of the common shares offered in the Offering to cover overallotments, if any. The Offering is subject to market conditions and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.
Calamp Corp. (NASDAQ: CAMP1.8% LOWER; reported Q1 EPS of $0.26, in-line with the analyst estimate of $0.26. Revenue for the quarter came in at $65.4 million versus the consensus estimate of $65.39 million. Calamp Corp. sees Q2 2015 EPS of $0.24-$0.28, versus the consensus of $0.26. Calamp Corp. sees Q2 2015 revenue of $66-70 million, versus the consensus of $68.08 million. Calamp Corp. sees FY2015 revenue of $280-290 million compared to the consensus of $282.77 million.
Apollo Investment (NASDAQ: AINV1.3% HIGHER; Jefferies initiated coverage with a Buy rating and a price target of $8.50.
Kohlberg Capital (NASDAQ: KCAP0.7% HIGHER; Cantor Fitzgerald initiated coverage with a Hold rating and a price target of $6.50.

Monday, June 29, 2015

Premarket Trading Ideas for June 30th: XIV, UWTI, GOGO, JUNO, ERX, ETRM, APOL, KITE, AMD, NBG, SVXY, VTAE, XLF, PRSN

Day Trading Ideas:
GOGO, XIV, APOL, JUNO
Economic calendar:
SessionTimeCurrencyEventImpactActualForecastPrev.
 2:00EURGerman Retail Salesmed 01.3
 2:00EURGerman Retail Salesmed 2.81
 2:45EURFrench PPImed  -0.4
 2:45EURFrench Consumer Spendinglow -0.20.1
 2:45EURFrench PPImed  -2
 2:45EURFrench Consumer Spendinglow 1.52
  3:55EURGerman Unemployment Rate (sa)high 6.46.4
  3:55EURGerman Unemployment Changemed -5-6
   5:00EURFlash HICP - Corehigh 0.80.9
   5:00EURFlash HICPhigh 0.20.3
   5:00EURUnemploymentmed 11.111.1
  9:00USDS&P Case-Shiller Home Pricemed 5.55.04
  9:45USDChicago PMImed 50.646.2
  10:00USDConsumer confidencehigh 97.195.4
  20:00USDVehicle Saleslow 17.217.71
  20:00EURECB minutes of previous meeting to be releasedhigh   

Premarket Earning Report:
ConAgra Foods, Inc. ( CAG ) is reporting for the quarter ending May 31, 2015. The food company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.59. This value represents a 7.27% increase compared to the same quarter last year. CAG missed the consensus earnings per share in the 2nd calendar quarter of 2014 by -3.51%. Zacks Investment Research reports that the 2015 Price to Earnings ratio for CAG is 20.28 vs. an industry ratio of 10.10, implying that they will have a higher earnings growth than their competitors in the same industry. 


Schnitzer Steel Industries, Inc. ( SCHN ) is reporting for the quarter ending May 31, 2015. The steel company's consensus earnings per share forecast from the 5 analysts that follow the stock is $-0.10. This value represents a 162.50% decrease compared to the same quarter last year. The last two quarters SCHN had negative earnings surprises; the latest report they missed by -312.5%. Zacks Investment Research reports that the 2015 Price to Earnings ratio for SCHN is -63.97 vs. an industry ratio of 2.10. 
OMNOVA Solutions Inc. ( OMN ) is reporting for the quarter ending May 31, 2015. The chemical company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.11. This value represents a 22.22% increase compared to the same quarter last year. The "days to cover" for this stock exceeds 13 days. Zacks Investment Research reports that the 2015 Price to Earnings ratio for OMN is 18.63 vs. an industry ratio of 17.40, implying that they will have a higher earnings growth than their competitors in the same industry.

After Hour Movers:
Juno Therapeutics, Inc. (Nasdaq: JUNO42.2% HIGHER; Celgene Corporation (Nasdaq: CELG) and Juno Therapeutics, Inc. (Nasdaq: JUNO) announced today a global collaboration for the development and commercialization of immunotherapies. The two companies will leverage T cell therapeutic strategies to develop treatments for patients with cancer and autoimmune diseases with an initial focus on Chimeric Antigen Receptor Technology (CAR-T) and T Cell Receptor (TCR) technologies. Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time.
EnteroMedics Inc. (NASDAQ: ETRM12.4% LOWER; commenced an underwritten public offering of units. Each unit will consist of a share of common stock, Series A warrants to purchase common stock and Series B warrants to purchase common stock.
Kite Pharma, Inc. (NASDAQ: KITE8.9% HIGHER; higher in sympathy with Juno
Apollo Education Group (NASDAQ: APOL6.7% LOWER; reported Q3 EPS of $0.44, $0.04 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $681.5 million versus the consensus estimate of $698.57 million. Third quarter 2015 University of Phoenix New Degreed Enrollment was 29,400 and Degreed Enrollment was 206,900, compared to New Degreed Enrollment of 33,900 and Degreed Enrollment of 241,900 for the prior year third quarter. Apollo Education Group sees FY2015 revenue of $2.60-2.62 billion, versus the consensus of $2.63 billion.
CHC Group (NYSE: HELI6.4% LOWER; reported Q4 EPS of ($0.55), $0.05 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $374 million versus the consensus estimate of $438.97 million.
Lion Biotechnologies, Inc. (NASDAQ: LBIO5.7% HIGHER; higher in sympathy with Juno
Cellectis S.A. (NASDAQ: CLLS3.8% HIGHER; higher in sympathy with Juno
Advanced Micro Devices (NASDAQ: AMD2.3% HIGHER; chatter Microsoft (NASDAQ: MSFT) may acquire AMD. The origin of the rumor is kitGuRu, citing sources. Microsoft approached AMD several months ago, the report said.
Celgene Corporation (Nasdaq: CELG0.7% LOWER; The company and Juno Therapeutics, Inc. (Nasdaq: JUNO) announced today a global collaboration for the development and commercialization of immunotherapies. The two companies will leverage T cell therapeutic strategies to develop treatments for patients with cancer and autoimmune diseases with an initial focus on Chimeric Antigen Receptor Technology (CAR-T) and T Cell Receptor (TCR) technologies. Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time.
American Capital Ltd (NASDAQ: ACAS0.4% HIGHER; announced today that in the second quarter of 2015 it made open market purchases of approximately 6.5 million shares of American Capital common stock, or 2.4% of the Company's outstanding shares as of March 31, 2015. The shares were purchased at an average price of $14.32 per share, totaling approximately $92.6 million.